Home BUSINESS Europe Markets: Valneva shares spike after saying vaccine candidate outperformed AstraZeneca’s

Europe Markets: Valneva shares spike after saying vaccine candidate outperformed AstraZeneca’s

29
0

Valneva’s wild stock-price rise continued on Monday after the French biotech said its coronavirus vaccine candidate outperformed AstraZeneca’s in a trial.

Valneva FR:VLA VALNshares rose as much as 46% after it said a Phase 3 trial showed its vaccine candidate, VLA2001, outperformed AstraZeneca’s UK:AZN in a trial of 4,012 people, with a significantly more favorable tolerability profile. Valneva said its vaccine produced more neutralized antibodies and there was a complete absence of any severe COVID-19 cases.

Even…

Topclassicnews

What do you think about this?